What is Geron's EBITDA?

Geron (GERN) reported EBITDA of $292K in Q1 2026.

How has Geron's EBITDA changed year-over-year?

Geron's EBITDA increased by 101.8% year-over-year, from -$16.57M to $292K.

What is the long-term trend for Geron's EBITDA?

Over 4 years (2021 to 2025), Geron's EBITDA has grown at a -12.0% compound annual growth rate (CAGR), from -$113.78M to -$68.11M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Geron GERN EBITDA

EBITDA at other companies

ImmunomeIMNM

-$58.73M-33.4%

Syndax PharmaceuticalsSNDX

-$30.2M+63.9%

Arcus BiosciencesRCUS

-$132M-10.9%

CelcuityCELC

-$50.46M-39.8%

Bristol-Myers SquibbBMY

——

IncyteINCY

——

Other financials

Income statement

See full

Revenue$51.8M+30.9%

Operating income$158.0K+101%

Net income-$3.6M+81.6%

EPS (diluted)-$0.01+66.7%

Balance sheet

See full

Cash & equivalents$48.7M-12.2%

Total debt$134.0M+10.0%

Total equity$229.1M-14.6%

Total assets$534.1M-5.0%

Cash flow

See full

Operating cash flow-$62.9M-31.1%

CapEx$206.0K+2.0%

Free cash flow-$43.8M-6.8%

Valuation

See full

Market cap$888.51M-8.6%

Enterprise value$973.78M-6.2%

P/S4.7×-174×

Profitability

See full

Operating margin-705.5%-351pp

Net margin-682.5%-339pp

FCF margin-734.4%-365pp

Returns & leverage

See full

Return on equity-27.1%-7.8pp

Debt / equity0.6×+0.1×

Current ratio6.8×-1.1×

Where this comes from

Calculated from Geron’s reported figures.

$158.0Kebit+

$134.0KDepreciation Depletion & Amortization

=$292K

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Geron's EBITDA?: Geron (GERN) reported EBITDA of $292K in Q1 2026.
How has Geron's EBITDA changed year-over-year?: Geron's EBITDA increased by 101.8% year-over-year, from -$16.57M to $292K.
What is the long-term trend for Geron's EBITDA?: Over 4 years (2021 to 2025), Geron's EBITDA has grown at a -12.0% compound annual growth rate (CAGR), from -$113.78M to -$68.11M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.